Patents by Inventor Budd A. Tucker

Budd A. Tucker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MICRORNA INHIBITOR SYSTEM AND METHODS OF USE THEREOF
    Publication number: 20230374509
    Abstract: The present invention relates to an expression-based RNA therapeutic that uses virus-based delivery of anti-miR181 (TuD-181). The present invention provides a method for treatment of Parkinson's disease (PD) by administering an expression-based RNA therapeutic that uses virus-based delivery of anti-miR181 (TuD-181). The present invention provides a method for treatment of retinal degeneration by administering an expression-based RNA therapeutic that uses virus-based delivery of anti-miR181 (TuD-181).
    Type: Application
    Filed: March 10, 2023
    Publication date: November 23, 2023
    Inventors: Ryan L. Boudreau, Colleen S. Stein, Budd Tucker
  • LOW OXYGEN CULTURE CONDITIONS FOR MAINTAINING RETINAL PROGENITOR CELL MULTIPOTENCY
    Publication number: 20230313135
    Abstract: The present invention relates to methods for culturing human retinal progenitor cells under low oxygen conditions to allow the cells to retain the ability to differentiate into photoreceptors following transplantation. The described methods provide cells that can treat a number of ocular diseases, including retinitis pigmentosa and age-related macular degeneration.
    Type: Application
    Filed: June 5, 2023
    Publication date: October 5, 2023
    Inventors: Michael J. Young, Budd A. Tucker, Petr Y. Baranov
  • LOW OXYGEN CULTURE CONDITIONS FOR MAINTAINING RETINAL PROGENITOR CELL MULTIPOTENCY
    Publication number: 20210198625
    Abstract: The present invention relates to methods for culturing human retinal progenitor cells under low oxygen conditions to allow the cells to retain the ability to differentiate into photoreceptors following transplantation. The described methods provide cells that can treat a number of ocular diseases, including retinitis pigmentosa and age-related macular degeneration.
    Type: Application
    Filed: December 23, 2020
    Publication date: July 1, 2021
    Inventors: Michael J. Young, Budd A. Tucker, Petr Y. Baranov
  • Low oxygen culture conditions for maintaining retinal progenitor cell multipotency
    Patent number: 10947501
    Abstract: The present invention relates to methods for culturing human retinal progenitor cells under low oxygen conditions to allow the cells to retain the ability to differentiate into photoreceptors following transplantation. The described methods provide cells that can treat a number of ocular diseases, including retinitis pigmentosa and age-related macular degeneration.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: March 16, 2021
    Assignee: The Schepens Eye Research Institute
    Inventors: Michael J. Young, Budd A. Tucker, Petr Y. Baranov
  • LOW OXYGEN CULTURE CONDITIONS FOR MAINTAINING RETINAL PROGENITOR CELL MULTIPOTENCY
    Publication number: 20170335280
    Abstract: The present invention relates to methods for culturing human retinal progenitor cells under low oxygen conditions to allow the cells to retain the ability to differentiate into photoreceptors following transplantation. The described methods provide cells that can treat a number of ocular diseases, including retinitis pigmentosa and age-related macular degeneration.
    Type: Application
    Filed: June 2, 2017
    Publication date: November 23, 2017
    Applicant: The Schepens Eye Research Institute
    Inventors: Michael J. Young, Budd A. Tucker, Petr Y. Baranov
  • Low oxygen culture conditions for maintaining retinal progenitor cell multipotency
    Patent number: 9677050
    Abstract: The present invention relates to methods for culturing human retinal progenitor cells under low oxygen conditions to allow the cells to retain the ability to differentiate into photoreceptors following transplantation. The described methods provide cells that can treat a number of ocular diseases, including retinitis pigmentosa and age-related macular degeneration.
    Type: Grant
    Filed: October 17, 2013
    Date of Patent: June 13, 2017
    Assignee: The Schepens Eye Research Institute
    Inventors: Michael J. Young, Budd A. Tucker, Petr Y. Baranov
  • LOW OXYGEN CULTURE CONDITIONS FOR MAINTAINING RETINAL PROGENITOR CELL MULTIPOTENCY
    Publication number: 20140140965
    Abstract: The present invention relates to methods for culturing human retinal progenitor cells under low oxygen conditions to allow the cells to retain the ability to differentiate into photoreceptors following transplantation. The described methods provide cells that can treat a number of ocular diseases, including retinitis pigmentosa and age-related macular degeneration.
    Type: Application
    Filed: October 17, 2013
    Publication date: May 22, 2014
    Applicant: The Schepens Eye Research Institute
    Inventors: Michael J. Young, Budd A. Tucker, Petr Y. Baranov
  • Low oxygen culture conditions for maintaining retinal progenitor cell multipotency
    Patent number: 8563304
    Abstract: The present invention relates to methods for culturing human retinal progenitor cells under low oxygen conditions to allow the cells to retain the ability to differentiate into photoreceptors following transplantation. The described methods provide cells that can treat a number of ocular diseases, including retinitis pigmentosa and age-related macular degeneration.
    Type: Grant
    Filed: June 14, 2011
    Date of Patent: October 22, 2013
    Assignee: The Schepens Eye Research Institute
    Inventors: Michael J. Young, Budd A. Tucker, Petr Y. Baranov
  • LOW OXYGEN CULTURE CONDITIONS FOR MAINTAINING RETINAL PROGENITOR CELL MULTIPOTENCY
    Publication number: 20120321593
    Abstract: The present invention relates to methods for culturing human retinal progenitor cells under low oxygen conditions to allow the cells to retain the ability to differentiate into photoreceptors following transplantation. The described methods provide cells that can treat a number of ocular diseases, including retinitis pigmentosa and age-related macular degeneration.
    Type: Application
    Filed: June 14, 2011
    Publication date: December 20, 2012
    Applicant: THE SCHEPENS EYE RESEARCH INSTITUTE
    Inventors: Michael J. Young, Budd A. Tucker, Petr Y. Baranov